STAGE IIIA BREAST CANCER AJCC V7
Clinical trials for STAGE IIIA BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIA BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Keytruda takes on genetic weak spots in advanced tumors
Disease control OngoingThis phase 2 trial tests whether pembrolizumab (Keytruda) can shrink or control advanced solid tumors that have certain gene mutations (BRCA1, BRCA2, POLE, POLD1). The study enrolled 21 adults with cancers that have spread or come back. Researchers measure how many patients see t…
Matched conditions: STAGE IIIA BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Could a gel help fight breast cancer? early trial underway
Disease control OngoingThis early-phase trial is testing whether a gel form of the drug endoxifen can be safely applied to the skin in women scheduled for breast surgery. The study includes 32 women with various stages of breast cancer or high genetic risk. Researchers are checking for skin reactions a…
Matched conditions: STAGE IIIA BREAST CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of two drugs, cediranib and olaparib, in people with advanced solid tumors that have spread or cannot be removed by surgery. The cancers include certain types of breast, lung, and pancreatic cancer. The goal is to see if the combination can shrink t…
Matched conditions: STAGE IIIA BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
New drug Z-Endoxifen takes on tamoxifen in breast cancer battle
Disease control OngoingThis study tests whether a newer drug, Z-Endoxifen, works better than the standard tamoxifen for postmenopausal women with advanced ER+/HER2- breast cancer. About 81 participants will receive one of the two hormone therapies to see which delays cancer growth longer. The goal is t…
Matched conditions: STAGE IIIA BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Can acupuncture ease breast cancer pain? new trial investigates
Symptom relief OngoingThis phase 2 trial tests whether electroacupuncture can reduce chronic pain in women who have completed treatment for stage I-III breast cancer. 111 participants will receive either real acupuncture, sham acupuncture, or no treatment. The goal is to see if this gentle needle ther…
Matched conditions: STAGE IIIA BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 23, 2026 11:55 UTC
-
Could 3 weeks of radiation be as good as 5 for breast cancer?
Symptom relief OngoingThis study compares a 3-week course of radiation to the standard 5-week course for breast cancer patients who need radiation to the lymph nodes. The goal is to see if the shorter schedule is just as effective at preventing cancer from coming back, while causing less arm swelling …
Matched conditions: STAGE IIIA BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 22, 2026 12:01 UTC